Myeloid-derived suppressor cells as therapeutic target in hematological malignancies.
De Veirman K, Van Valckenborgh E, Lahmar Q, Geeraerts X, De Bruyne E, Menu E, Van Riet I, Vanderkerken K, Van Ginderachter JA.
De Veirman K, et al. Among authors: van ginderachter ja, van valckenborgh e, van riet i.
Front Oncol. 2014 Dec 8;4:349. doi: 10.3389/fonc.2014.00349. eCollection 2014.
Front Oncol. 2014.
PMID: 25538893
Free PMC article.
Review.